NEW YORK (GenomeWeb) – Investment bank UBS has initiated coverage of the genomics and molecular diagnostics space, saying technology advances will enable "the next wave of transformative innovations that will impact nearly every aspect of our lives," while "creating a unique opportunity for investors." 

Analyst Jon Groberg initiated coverage on a total of 16 firms, and gave six companies Buy ratings, nine companies Neutral ratings, and one firm a Sell rating. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.